Wirksamkeit von Etidronat und sequenziellem Monofluorphosphat bei schwerer postmenopausaler Osteoporose

Autor: H. Faber, I. Setnikar, Johann D. Ringe, L. C. Rovati, C. Kipshoven, A. Dorst

Publikováno v: Arthritis und Rheuma. 26:15-21

ZusammenfassungInnerhalb einer dreijährigen Pilotstudie an 52 Frauen mit schwerer postmenopausaler Osteoporose wurden die Behandlungen mit Etidronat und anschließender Gabe von Kalzium und Vitamin D (ECaD) einerseits bzw. mit Etidronat und anschlie

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::bbcb7a855c457a2dfee3623eefe8efa5
https://doi.org/10.1055/s-0037-1618528

Irish society of gastroenterology

Autor: J. Gilvarry, John M. Fitzpatrick, N. Williams, J. Stinson, R. B. Stephens, Y. Ellias, A. Chua, H. Hamilton, G. O’Dowd, E. O’Broin, B. G. Gazzard, J. Crowe, K. Ashbury, P. Kent, J. Feely, M. Abuzakouk, N. Barrett, Frank Kee, P. W. Hamilton, S. Somasundaram, M. Kelly, T. P. J. Hennessy, P. Broe, T. P. Caldwell, E. Casey, M. Stagg, John V. Reynolds, P. Lawlor, D. G. Weir, D. O’Donovan, Thomas F. Gorey, N. O’Donovan, Kevin O'Malley, S. Beattie, F. Khan, J. Keating, M. Neligan, M. D. McCaigue, T. Hennebry, Michael J. Kerin, E. M. Murray, M. Morrin, Timothy G. Dinan, Cliona O'Farrelly, J. Donohoe, John P. Burke, G. O’Sullivan, David Bouchier-Hayes, I. Menzies, X. J. Fan, R. J. Moorehead, N. Noonan, G. R. Barclay, G. Burke, L. C. Rovati, P. McMathuna, B. Rowlands, A. Ireland, H. Fenlon, A. M. O’Mahony, P. Erwin, S. E. H. Russell, C. Bergin, D. Kidney, C. Fallon, M. I. Halliday, C. O. Morain, F. Keeling, A. Duggan, P. Gillen, F. Malone, Maria M. Buckley, Mary Toner, Denis Evoy, W. A. Tanner, F. Loughnane, N. Mahmud, B. J. Rowlands, D. Evoy, N. Hall, Conleth Feighery, J. Geraghty, C. Kelly, C. A. O’Morain, M. Regan, D. P. O’Donoghue, Brendan M. Walsh, M. O’ Brien, Colm O'Morain, T. N. Walsh, H. Mulcahy, J. Smithson, W. Watson, S. E. A. Attwood, Alan W. Baird, M. C. R. Whiteside, Simon Keely, P. W. N. Keeling, G. McEntee, D. B. Stafford Johnson, Paul E. Burke, S. Dudley, N. Couse, O. Traynor, Dermot Kelleher, D. Bouchier Hayes, M. McCaigue, D. Bouchier-Hayes, P. J. Erwin, S. Cameron, J. Drebin, N. H. Anderson, Martin J. O’Sullivan, W. A. Stack, Fergal J. O'Brien, R. J. Maxwell, R. H. Wilson, M. McCarthy, Patrick J. Byrne, E. Mooney, Frank B. V. Keane, B. Clements, I. Bjarnason, R. J. Cahill, G. Thornton, M. Jeffers, B. Golden, P. V. Delaney, N. Brindley, Maria A. O'Connell, N. Francis, M. G. Goggins, P. Marks, K. R. Gardiner, J. K. Collins, X. G. Fan, K. Mealy, Donald G. Weir, P. Redmond, M. T. P. Caldwell, I. Halliday

Publikováno v: Irish Journal of Medical Science. 162:362-375

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::a20e4a79f9ea24d275cfa8e84ded325c
https://doi.org/10.1007/bf02942168

Absorption, distribution, metabolism and excretion of glucosamine sulfate. A review

Autor: I, Setnikar, L C, Rovati

Publikováno v: Arzneimittel-Forschung. 51(9)

This article reviews the literature related to the absorption, distribution, metabolism and excretion (ADME) of glucosamine (Gl) in man and in animals after administration of crystalline glucosamine sulfate (CGS). Intravenous administration of CGS In

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::d28634dd1d8e789e4d291e9eac20891f
https://pubmed.ncbi.nlm.nih.gov/11642003

Efficacy on climacteric symptoms and safety of low dose estradiol transdermal matrix patches. A randomized, double-blind placebo-controlled study

Autor: D, De Aloysio, L C, Rovati, G, Giacovelli, I, Setnikar, F, Bottiglioni

Publikováno v: Arzneimittel-Forschung. 50(3)

Two estradiol (E2) transdermal patches releasing 25 micrograms/day E2 (D-25) or 37.5 micrograms/day E2 (D-37.5) were compared to a placebo patch on 156 patients in natural or surgical menopause suffering from at least 5 hot flushes per day, randomly

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::956ffcdb44a7bf7811826a9444f51376
https://pubmed.ncbi.nlm.nih.gov/10758784

Bioavailability and pharmacokinetic characteristics of two monofluorophosphate preparations with calcium supplement

Autor: I, Setnikar, L C, Rovati, K, Schmid, B, Vens-Cappell, M F, Barkworth

Publikováno v: Arzneimittel-Forschung. 48(12)

Two studies on the rate and extent of bioavailability of fluoride from a single dose of oral preparations of sodium monofluorophosphate (Na2FPO3) combined with calcium supplement were conducted according to a cross-over design on 18 (Study 1) and 20

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::a0e49fc960daf256094a7e16f8eb6fde
https://pubmed.ncbi.nlm.nih.gov/9893933